Lucara Slashes Outlook Following Severed HB Deal

RAPAPORT®
NewsBrief  
November 14, 2023
 
linkedin   facebook   twitter   instagram   youtube
 
 
Lucara Slashes Outlook Following Severed HB Deal
Lucara Diamond Corp. has lowered its full-year forecast due to the termination of its supply agreement with HB, as well as the broader slowdown in the rough market.
Colored Stones Steal Spotlight at AGTA Awards
Opal ring and set of Paraiba tourmalines take Best of Show honors in Spectrum and Cutting Edge contests.
 
Early Discounts Drive October Online Holiday Spending
Sales for the month up 6% year on year, according to Adobe Analytics.
 
Asia Rebound Boosts Richemont Jewelry Sales
Revenue up 10% year on year in first half.
News Digest
Diamond Certification Head Hits Out at G7 Plans to Target Russian Producers
Subscription Required
(Financial Times)
 
De Beers Keeps Production Target Despite Supply Glut
(Reuters)
 
Daniel Arsham and Tiffany & Co. Just Dropped a New Collection of Pokémon Necklaces
(Robb Report)
 
Events
LinkedIn Live: The Ins and Outs of Diamond Screening
November 14
10 a.m. EST
Join Us
 
Rapaport Melee Auction
November 14-22
New York & Dubai
More Details
 
Rapaport Single Stone Auction
November 21-29
New York & Israel
More Details
RapNet Diamond Index (RAPI™)
Diamond Data
Size
Index
Weekly
Monthly
Y2Y
 0.30 ct
1,402
0.29%
-0.17%
-4.45%
 0.50 ct
1,925
0.25%
0.51%
-28.87%
 1.00 ct
5,958
0.25%
0.10%
-23.22%
 3.00 ct
22,095
-0.02%
0.04%
-13.07%
Rapaport Investment Grade Diamonds
CONTACT US
Facebook logo       Twitter logo       LinkedIn logo       RSS logo       Email logo
© Copyright 2023 by Rapaport USA Inc. All Rights Reserved.
Rapaport®, TradeWire®, RapNet®, Index® and JNS® Jewelry News Service are
registered trademarks.
Rapaport USA 133 East Warm Springs Road Suite 100 Las Vegas Nevada 89119 USA
You received this email because you are subscribed to Daily NewsBrief from Rapaport USA.
Update your email preferences to choose the types of emails you receive.
Unsubscribe from all future emails

Post a Comment

0 Comments